CompanyPBYINasdaqLos Angeles, CA

Puma Biotechnology, Inc.

SEC EDGAR ClinicalTrials.gov pumabiotechnology.com

10-QAug 6Latest SEC filing, period to Jun 30

Aug 6Latest story

August 2026

Puma Biotechnology raises 2026 guidance on NERLYNX demand, details alisertib trial timeline

Aug 6Quarterly updatealisertib neratinib